Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Hepatic HuR protects against atherosclerosis through bile acid production

ABSTRACT: Hepatocyte-specific HuR knockout mice exhibit a lean MAFLD (metabolic-associated fatty liver disease)-like phenotype in response to high-fat diet. However, if this phenotype further impacts the development of atherosclerosis (AS) remains to be studied. Here, we report that HuR represses the production of chenodeoxycholic acid (CDCA) and taurocholic acid (TCA) in the liver through repressing the expression of CYP7A1, the rate-limiting enzyme for the central pathway of BA production. HuR destabilizes Cyp7a1 mRNA by associating with its 3’UTR. In response to high-cholesterol diet (HCD), hepatic HuR increases the expression of CYP7A1 in the liver, thereby increasing the levels of CDCA and TCA in the liver and serum, activating HuR-PSPF (platelet-secreted pro-inflammatory factors) regulatory process, and aggravating HCD-induced AS in APOE (-/-) mice. Administration of TCA and CDCA activates HuR-PSPF regulatory process and at the same time aggravates HCD-induced AS. Platelet HuR ablation mitigates the effect of hepatic HuR ablation in aggravating HCD-induced AS. In the liver tissues from patients with lean MAFLD, the reduction of HuR expression, the induction of CYP7A1 expression and the activation of HuR-PFPF regulatory process, are concurrently observed. Our findings suggest an important role of hepatic HuR-CYP7A1 regulatory process in the development of AS in lean MAFLD-like lipid dysregulation.

ORGANISM(S): Mus musculus Homo sapiens

PROVIDER: GSE326269 | GEO | 2026/05/31

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Iron deficiency promotes bile acid deposition in an m6A-YTHDF2-CYP7A1 dependent mechanism

Project description:Background: Iron deficiency anemia is a major challenge in in both human health and animal husbandry. Disrupted bile acid metabolism is a key characteristic among people with anemia. However, effects and mechanisms of iron deficiency on bile acid metabolism remain unclear. N6-methyladenine (m6A) is the most abundant epigenetic modification, which can regulate various nutrient metabolism. This study aimed to investigate effect of iron deficiency on bile acid metabolism and elucidate its mechanism from the perspective of m6A methylation. Results: Iron deficiency (ID) destroyed liver morphology and ultrastructure in suckling piglet. Notably, ID induced moderate dilation of the endoplasmic reticulum and a reduction in mitochondrial number. At the metabolite level, ID significantly promoted bile acid deposition and reshaped bile acid profile. Specifically, ID decreased contents of GCA, CDCA, and 6-KetoLCA, while increasing levels of THDCA, TωMCA, DCA, GDCA, and TDCA (P < 0.05). At the molecular level, ID upregulated CYP7A1 expression to promoted bile acid deposition. Moreover, ID significantly decreased m6A content, and reduced expression of FTO and YTHDF2 (P < 0.05). M6A-seq data revealed an increase in m6A methylated peaks on CYP7A1 under ID condition. Importantly, RNA immunoprecipitation and stability experiments demonstrated YTHDF2 could bind and decrease stability of CYP7A1 (P < 0.05). Mechanistically, ID reduced YTHDF2 expression, thereby stabilizing CYP7A1 and driving bile acid accumulation. Conclusion: Iron deficiency induced bile acid deposition in an m6A-YTHDF2-CYP7A1 dependent manner, which further causes liver injury.

2026-02-18 | GSE304597 | GEO

Urine proteome in patients with metabolic associated fatty liver disease

Project description:Background Metabolic associated fatty liver disease (MAFLD) was recently proposed to replace non-alcoholic fatty liver disease (NAFLD), which is defined as ectopic fat deposition in the liver. Hepatic steatosis is an independent predictor for insulin resistance and cardiovascular risk and hence mortality. The aim of present study was to investigate the urine molecular pattern and potential urine biomarker to distinguish healthy control, mild and severe hepatic steatosis in MAFLD patients using proteomic data. Method Hepatic steatosis was measured by Magnetic resonance imaging (MRI) that measure the proton density fat fraction (MRI-PDFF). Proteomic measurements of urine samples were done by mass spectrometry. Linear regression analyses were used to detect significant associations between the biomarkers and clinical parameters. Western blot and Elisa were performed for validation. Results Multiple pathways have been compromised in MAFLD, including the carbohydrate derivative catabolic process, glycosaminoglycan process, aminoglycan metabolic process, inflammatory response, insulin-like growth factor receptor and GTPase complex. Alpha-1-acid glycoprotein 1 (ORM1) and ceruloplasmin were finally identified to be potential urine biomarkers to detect mild/severe hepatic steatosis.

2022-08-12 | PXD026333 | Pride

Circadian disruption exacerbates MASH in mice by reducing intestinal Akkermansia muciniphila abundance via the FXR-CYP7A1-bile acid axis_Targeting Bile Acids

Project description:<p>Circadian disruption has emerged as a significant public health issue and is increasingly recognized as a contributor to the progression of metabolic dysfunction-associated steatotic liver disease (MASLD), though the underlying mechanisms remain poorly understood. In this study, we established a mouse model combining continuous light exposure and a western diet to investigate how circadian disruption exacerbates metabolic dysfunction-associated steatohepatitis (MASH). Our results demonstrated that circadian disturbance aggravated hepatic inflammation, lipid accumulation, and intestinal barrier impairment. Through integrated 16S rRNA sequencing and metabolomic analyses, we identified a marked reduction in Akkermansia muciniphila abundance and an elevation in CDCA-3S. Supplementation with A. muciniphila, taurine, or the FXR agonist obeticholic acid restored microbial and metabolic homeostasis, subsequently alleviating MASH pathology. Mechanistically, our data suggest these beneficial effects may involve the FXR–CYP7A1 signaling pathway. Our findings indicate that circadian disruption aggravates MASH potentially through reducing A. muciniphila abundance in a process associated with the FXR–CYP7A1–bile acid axis , and highlight the potential of microbial and metabolic interventions as novel therapeutic strategies for individuals with sleep-related circadian disorders.</p>

2026-02-05 | MTBLS13845 | MetaboLights

Circadian disruption exacerbates MASH in mice by reducing intestinal Akkermansia muciniphila abundance via the FXR-CYP7A1-bile acid axis_Targeting Bile Acids_Untargeted Serum Metabolomics

2026-02-05 | MTBLS13848 | MetaboLights

Bulk Liver in MAFLD/MASH

Project description:Background & Aims: Metabolic dysfunction associated steatotic liver disease (MAFLD) progresses to steatohepatitis (MASH) and is a major cause of liver cirrhosis. In the early disease stage, liver inflammation is absent. However, the early involvement of the peripheral immune cell compartments in disease progression is poorly understood and single cell profiles of peripheral immune cells in MAFLD/MASH are not known. Methods: MAFLD/MASH patients and healthy volunteers have been prospectively enrolled into a cross-sectional study. Patients have been histologically stratified and characterized by liver bulk RNA-Seq.

2025-04-30 | GSE267031 | GEO

Differences in gene expression of liver tissues between MAFLD patients and controls.

Project description:Transcriptomic analysis was applied to liver tissues of seven patients with MAFLD and nine normal controls,then, differential genes were identified by comparative analysis of sequencing results, and target genes that may be related to the pathogenesis of MAFLD were further studied.This study may provide new ideas for understanding the pathogenesis of MAFLD and thus provide new targets for the treatment of MAFLD.

2021-12-14 | GSE183229 | GEO

Bulk White Blood Cells in MAFLD/MASH

2025-04-30 | GSE267032 | GEO

Genome-wide analysis of chronic inflammation induced gene expression in livers isolated from either wild type or ApoE-Cyp7a1 transgenic animals.

Project description:Analysis of whole genome expression changes in livers from wild type animals and animals with a liver specific transgenic over expression of Cyp7a1. Mice were given a chronic, repetitive administration of LPS for 7 days. Our prior analysis had indicated that inflammation suppresses Cyp7a1 and that this leads to accumulation of intermediates in the mevalonate biosynthesis pathway. Here, we hypothesized that over expression of Cyp7a1 would not affect the changes in transcriptional state due to chronic administration of LPS. We provide gene expression data which evaluates this question. Here we find that over expression of Cyp7a1 minimally alters the transcriptome of livers in an untreated state, and that it has small effects on the response to chronic LPS. Total RNA isolated from livers of wild type and liver specific Cyp7a1 transgenic animals treated with or without recurrent, daily LPS injections (1.5mg/kg) for 7 days. There are two biological replicates per condition. Samples are a matrix of all conditions reported as FPKMs.

2016-03-17 | E-GEOD-75477 | biostudies-arrayexpress

NKG2D-mediated immunosensing of metabolically stressed hepatocytes by innate-like T cells is essential for initiation of NASH and fibrosis

Project description:Metabolic-associated fatty liver disease (MAFLD) comprises a spectrum of clinical entries ranging from benign steatosis to cirrhosis. A key event in the pathophysiology of MAFLD is the development of non-alcoholic steatohepatitis (NASH) that may lead to fibrosis and hepatocellular carcinoma. What triggers inflammation in MAFLD is unknown. We find that lipid accumulation in hepatocytes induces expression of ligands for the activating immune receptor NKG2D. Tissue-resident innate-like T cells are activated through NKG2D and secrete IL-17A. IL-17A licenses hepatocytes to produce chemokines that recruit pro-inflammatory cells into the liver, causing NASH and fibrosis. NKG2D-deficient mice did not develop fibrosis in a dietary model for NASH and had a marked decrease in the incidence of hepatic tumors. Importantly, the frequency of IL-17A+ γδ T cells in the blood MAFLD patients correlated with liver pathology. Our findings identify a key molecular mechanism through which stressed hepatocytes trigger inflammation in context of MAFLD.

2022-04-11 | GSE200482 | GEO

Liver gene expression profile _ wild type_ CYP7A1 transgenic

Project description:Bile acids are not only physiological detergents facilitating nutrient absorption, but also signaling molecules regulating metabolic homeostasis. We reported recently that transgenic expression of CYP7A1 in mice stimulated bile acid synthesis and prevented Western diet-induced obesity, insulin resistance and hepatic steatosis. The aim of this experiment is to determine the impact of induction of hepatic bile acid synthesis on liver metabolism by determining hepatic gene expression profile in CYP7A1 transgenic mice. CYP7A1 transgenic mice and wild type control mice were fed either standard chow diet or high fat high cholesterol Western diet for 4 month. Hepatic gene expressions were measured by microarray analysis. Our results indicate that hepatic bile acid synthesis is closely linked to cholesterogenesis and lipogenesis, and maintaining bile acid homeostasis is improtant in hepatic metabolic homeostasis. Male aged matched (~ 12-14 weeks) CYP7A1 transgenic mice and their wild type control littermates were fed a standard chow diet or a high fat (42%) high cholesterol (0.2%) diet (Harlan Teklad #88137) for 4 month Four groups (4 mice/group) are included in the experiments: Group 1: WT _ Chow Group 2: CYP7A1-tg + chow Group 3: WT + Western diet Group 4: CYP7A1-tg _ Western diet Total liver mRNA was isolated with a RNeasy kit (Qiagen) and used for microarray analysis.

2013-08-15 | E-GEOD-38872 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data